Texas will receive $1 million as part of a multi-state settlement with the New York based pharmaceutical giant Bristol-Myers Squibb for improper marketing of its anti-psychotic drug Abilify. Without regulatory approval, Bristol-Myers Squibb promoted Ailify to treat elderly patients with dementia but did not disclose dementia patients faced a greater risk of death.

Topics:  new york   abilify   ailify   bristol-myers squibb   texas   million   drug   marketing   dementia   patients   
BING NEWS:
  • The Mattress Tycoon Funding the Far Right in Texas
    Together, the McIngvales leaped into the national spotlight in 2022, when Mack won what is believed to be the largest sports bet in history—an estimated $75 million—after the Astros won the ...
    03/19/2024 - 1:00 pm | View Link
  • Texas AG Sues Pfizer Over Covid Vaccine Effectiveness
    The lawsuit alleges Pfizer violated Texas’ Deceptive Trade Practices Act by ... a former Food & Drug Administration director and a member of Pfizer’s executive committee at the time, contacted ...
    11/30/2023 - 9:42 am | View Link
  • Texas AG Paxton suing Pfizer for attempted censorship, ‘misrepresenting’ COVID-19 vaccination
    In his announcement, Paxton accused Pfizer of violating the Texas Deceptive Trade Practices Act ... More than 366 million doses of Pfizer’s original coronavirus vaccine were administered in ...
    11/30/2023 - 8:30 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News